海王英特龙2023年第三季度报告

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

2018 Third Q%5Cuarterly Report 第三季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

Third Q%5Cuarterly Report 2022第三季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

2023 First Q%5Cuarterly Report 第一季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

Third Q%5Cuarterly Report 2017第三季度報告 2017 香港聯合交易所有限公司（「聯交所」）創業板（「創業板」）特色 創業板的定位，乃為相比起其他在聯交所上市的公司帶有較高投資風險的公司提供一個上市的市場。有意投資的人士應了解投資 於該等公司的潛在風險，並應經過審慎周詳的考慮後

海王英特龙秉持「健康成就未来」的理念，以现代生物技术与药物制剂技术为创新平台，发展细胞因子类蛋白质治疗药物和预防用生物制品，创建以自主知识产权产品研发和专业化营销能力为代表的核心竞争力，逐步确立国内市

海王英特龙秉持「健康成就未来」的理念，以现代生物技术与药物制剂技术为创新平台，发展细胞因子类蛋白质治

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s